WordNet

immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
of or relating to or caused by streptococci (同)streptococcic, strep

PrepTutorEJDIC

牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
連鎖球菌の(による)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. B群レンサ球菌感染症予防のための予防接種vaccines for the prevention of group b streptococcal disease [show details]
…underlying medical conditions Vaccination strategies and the composition of potential GBS vaccines are reviewed here. The microbiology and epidemiology GBS infections are discussed separately. GBS …
2. 妊娠していない成人におけるB群レンサ球菌感染症group b streptococcal infections in nonpregnant adults [show details]
… nonpregnant adults. GBS infection in nonpregnant adults will be reviewed here. The microbiology of infections caused by this organism and prevention strategies through chemoprophylaxis and vaccination are discussed …
3. 連鎖球菌性咽頭炎の治療および予防treatment and prevention of streptococcal pharyngitis [show details]
… No vaccine against GAS is available for clinical use. However, research on GAS vaccine development is ongoing . An important area of uncertainty is whether vaccine-induced antibodies… group A streptococcal tonsillopharyngitis is reviewed here. The clinical features and diagnostic evaluation of patients with tonsillopharyngitis are discussed separately. Group A Streptococcus (GAS)…
4. A群レンサ球菌：病原性因子および発症機序group a streptococcus virulence factors and pathogenic mechanisms [show details]
… emm types in a proposed 26-valent vaccine accounted for 79 percent of isolates, for 85 and 88 percent of isolates implicated in necrotizing fasciitis and streptococcal toxic shock syndrome (TSS), respectively …
5. 新生児および乳児におけるB群レンサ球菌感染症group b streptococcal infection in neonates and young infants [show details]
… have specific risk factors for early-onset GBS infection; Vaccination of all women when GBS vaccines become available; Screening programs, IAP, and vaccination to prevent GBS disease are discussed separately …

English Journal

Prognosis of Streptococcus pneumoniae endocarditis in France, a multicenter observational study (2000-2015).

Périer A, Puyade M, Revest M, Tattevin P, Bernard L, Lemaignen A, Boutoille D, Allal J, Roblot F, Rammaert B.
International journal of cardiology. 2019 Aug;288()102-106.
Streptococcus pneumoniae is responsible for <2% of infective endocarditis (IE). The aim of this study was to assess the prognosis of pneumococcal IE. This multicentric observational retrospective study included adult patients presenting with definite S. pneumoniae IE according to modified Dukes crit
PMID 31056415

Pneumococcal pep27 mutant immunization suppresses allergic asthma in mice.

Kim BG, Ghosh P, Ahn S, Rhee DK.
Biochemical and biophysical research communications. 2019 Jun;514(1)210-216.
Asthma is an allergic airway disease (AAD) characterized by eosinophilic inflammation, mucus hypersecretion, and airway hyper responsiveness, and it is caused by dysregulated immune responses. Conversely, regulatory T cells (Tregs) control aberrant immune responses and maintain homeostasis. Recent e
PMID 31029416

Molecular characterization, host defense mechanisms, and functional analysis of ERp44 from big-belly seahorse: A novel member of the teleost thioredoxin family present in the endoplasmic reticulum.

Liyanage DS, Omeka WKM, Lee J.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology. 2019 Jun;232()31-41.
Endoplasmic reticulum resident protein 44 (ERp44) is a protein disulfide isomerase (PDI) and a member of thioredoxin family, which is involved in several functions such as oxidative folding and polymerization of molecules, carrier protein activity, regulation of the Ca ion levels in the endoplasmic
PMID 30797055